US Patent 11278719 Delivery of implantable neurostimulators
Patent 11278719 was granted and assigned to BlueWind Medical on March, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11278719 Delivery of implantable neurostimulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
